A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses

por Cohen, E. E. W., Tortorici, M., Kim, S., Ingrosso, A., Pithavala, Y. K., Bycott, P.
Publicado 2014